IRIS - Res&Arch Institutional Research Information System - Research & Archive

PASQUALUCCI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.641
AS - Asia 3.146
EU - Europa 2.693
SA - Sud America 495
Continente sconosciuto - Info sul continente non disponibili 231
AF - Africa 73
OC - Oceania 1
Totale 11.280
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.507
SG - Singapore 1.460
IE - Irlanda 484
UA - Ucraina 458
HK - Hong Kong 439
IT - Italia 411
RU - Federazione Russa 382
BR - Brasile 376
VN - Vietnam 339
CN - Cina 338
SE - Svezia 271
KR - Corea 187
DE - Germania 159
FR - Francia 159
FI - Finlandia 118
GB - Regno Unito 85
TR - Turchia 82
IN - India 68
CA - Canada 61
AR - Argentina 46
BD - Bangladesh 45
IQ - Iraq 32
MX - Messico 30
PL - Polonia 27
AT - Austria 22
ZA - Sudafrica 21
BE - Belgio 20
NL - Olanda 20
CH - Svizzera 19
EC - Ecuador 19
UZ - Uzbekistan 19
SA - Arabia Saudita 18
JP - Giappone 16
ES - Italia 15
MA - Marocco 15
CO - Colombia 14
PK - Pakistan 12
LB - Libano 11
PH - Filippine 11
VE - Venezuela 11
CR - Costa Rica 10
DZ - Algeria 10
ID - Indonesia 10
GR - Grecia 9
CL - Cile 7
AZ - Azerbaigian 6
EG - Egitto 6
MY - Malesia 6
PY - Paraguay 6
UY - Uruguay 6
GE - Georgia 5
JM - Giamaica 5
KE - Kenya 5
KZ - Kazakistan 5
NP - Nepal 5
PA - Panama 5
PE - Perù 5
SV - El Salvador 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
CZ - Repubblica Ceca 4
IL - Israele 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
EE - Estonia 3
HN - Honduras 3
JO - Giordania 3
LT - Lituania 3
NG - Nigeria 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
CI - Costa d'Avorio 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
NI - Nicaragua 2
QA - Qatar 2
SN - Senegal 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
GT - Guatemala 1
HT - Haiti 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 11.041
Salva come PNG Salva come JPEG
Città #
Singapore 1.060
San Jose 660
Dublin 483
Chandler 443
Hong Kong 438
Ashburn 319
Jacksonville 252
San Mateo 251
Boardman 203
Dong Ket 202
Santa Clara 187
Seoul 186
Council Bluffs 172
Moscow 149
Altamura 135
Perugia 135
Medford 116
Princeton 116
Lauterbourg 109
Ann Arbor 97
Lawrence 90
Wilmington 86
Andover 66
Beijing 64
Izmir 57
New York 57
Los Angeles 50
Ho Chi Minh City 46
Dallas 43
Des Moines 43
The Dalles 43
Saint Petersburg 38
São Paulo 33
Hanoi 32
Piscataway 32
Norwalk 26
Helsinki 21
Montreal 21
Nuremberg 21
Phoenix 21
Brussels 20
Frankfurt am Main 20
Falls Church 19
Chicago 18
Belo Horizonte 17
Woodbridge 17
Amelia 16
Tokyo 15
Denver 14
Munich 14
Orem 14
Rio de Janeiro 14
Stockholm 14
Tashkent 14
West Jordan 14
Johannesburg 13
Brooklyn 12
Milan 12
San Paolo di Civitate 12
Warsaw 12
Istanbul 11
Shanghai 11
Baghdad 10
Chennai 10
Dearborn 10
Mexico City 10
Vienna 10
Amsterdam 9
Columbus 9
Haiphong 9
Houston 9
Philadelphia 9
San José 9
Toronto 9
Atlanta 8
Charlotte 8
Guangzhou 8
Hefei 8
Jeddah 8
London 8
Mumbai 8
Redwood City 8
Rome 8
Brasília 7
Casablanca 7
Nanning 7
Porto Alegre 7
Baku 6
Boston 6
Den Haag 6
Dhaka 6
Redmond 6
Secaucus 6
Algiers 5
Ankara 5
Buffalo 5
Da Nang 5
Frankfurt Am Main 5
Guarulhos 5
Guayaquil 5
Totale 7.210
Salva come PNG Salva come JPEG
Nome #
Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML. 178
A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. 164
Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma 157
BCL-6 in aids-related lymphomas: pathogenetic and histogenetic implications. 156
Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. 153
Antitumor activity of anti-CD30 immunotoxin (Ber-H2/saporin) in vitro and in severe combined immunodeficiency disease mice xenografted with human CD30+ anaplastic large-cell lymphoma. 151
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification 149
Anti-CD30 (BER=H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+ tumour cells in vitro and in SCID mice. 148
AID is required for germinal center-derived lymphomagenesis. 141
Lack of the ubiquitin-editing enzyme A20 results in loss of hematopoietic stem cell quiescence 134
Analysis of a 69-kb contiguous genomic sequence at a putative tumor suppressor gene locus on human chromosome 6q27. 134
Analysis of the coding genome of diffuse large B cell lymphoma 133
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype 132
BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. 131
Alterations of BIRC3 and multiple other NF-kB pathway genes in splenic marginal zone lymphoma 131
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. 129
Aberrant somatic hypermutation in tumor cells of nodular lymphocyte-predominant and classical Hodgkin's lymphoma. 126
Comparison of immunosuppressive effects of single-dose and hyperfractionated total body irradiation 125
BCL-6 mutations are associated with immunoglobulin variable heavy chain mutations in B-cell chronic lymphocytic leukemia. 125
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness 124
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation 124
Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. 122
Aberrant somatic hypermutation in post-transplant lymphoproliferative disorders. 122
Hypermutation of multiple proto-oncogenes in B-cell Diffuse Large Cell Lymphomas 118
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. 117
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML) 116
Bcl-6 protein expression in normal and neoplastic lymphoid tissues. 115
Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. 115
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. 115
B-cell receptor signaling derailed in lymphomas. 114
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype 113
BRAF mutations in hairy-cell leukemia. 112
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. 111
Molecular pathogenesis of germinal center-derived B cell lymphomas 109
The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3ß inhibition 106
Follicular lymphoma dynamics 105
Targeted antibodies in the treatment of lymphomas. 104
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. 103
Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. 103
Expression of the AID protein in normal and neoplastic B cells. 102
The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations. 102
Aberrant somatic hypermutation in tumor cells of nodular-lymphocyte-predominant and classic Hodgkin lymphoma. 101
Whole-Exome Sequencing Identifies Recurrent Mutations of BCOR in Acute Myeloid Leukemia with Normal Karyotype 100
Genetic and phenotypic analysis of B-cell post-transplant lymphoproliferative disorders provides insights into disease biology. 97
Pathology and Molecular Pathogenesis of DLBCL and Related Entities 97
Unique and Shared Epigenetic Programs of the CREBBP and EP300 Acetyltransferases in Germinal Center B Cells Reveal Targetable Dependencies in Lymphoma 93
Mediastinal large B-cell lymphoma: clinical and immunohistological findings in 18 patients treated with different third-generation regimens. 92
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression 92
Mutations in the RNA splicing factor SF3B1 promote tumorigenesis through MYC stabilization 92
Protein expression analysis of chromosome 12 candidate genes in chronic lymphocytic leukemia (CLL). 90
Proto-oncogenes and Tumor Suppressor Genes in Hematopoietic Malignancies 89
The CREBBP acetyltransferase is a haploinsufficient tumor suppressor in B-cell lymphoma 89
Inactivating mutations of acetyltransferase genes in B-cell lymphoma. 87
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome 86
Immunocytochemical diagnosis of acute promyelocytic leukemia (M3) with the monoclonal antibody PG-M3 (anti-PML). 86
Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis 86
Gli anticorpi monoclonali nella terapia delle emopatie maligne. 85
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. 85
Deregulated BCL6 expression recapitulates the pathogenesis of human diffuse large B cell lymphomas in mice. 85
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. 85
The genetics of nodal marginal zone lymphoma 85
Repurposing Dasatinib for diffuse large B cell lymphoma. 85
Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. 84
Genomic profiling for clinical decision making in lymphoid neoplasms 83
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. 83
Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma 83
Dissecting KMT2D missense mutations in Kabuki syndrome patients 82
Emerging epigenetic-modulating therapies in lymphoma 81
Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and an anti-CD22 monoclonal antibody (OM124): in vitro and in vivo studies. 80
IMMUNOCYTOCHEMICAL DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA (M3) WITH THE ANTI-PROMYELOCYTIC LEUKEMIA (ANTI-PML) MONOCLONAL ANTIBODY PG-M3 79
Molecular Biology of Lymphoma 79
Molecular pathogenesis of diffuse large B-cell lymphoma 78
MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis 78
Molecular Genetics of Lymphoma 77
The germinal center in the pathogenesis of B cell lymphomas 76
Mechanism of altered nucleo-cytoplasmic traffic of nucleophosmin in acute myelogenous leukemia carrying exon12 NPM mutations (NPMc plus AML). 76
Epigenetic Rewiring of BCR Signaling as a Novel Mechanism of Ibrutinib Resistance in ABC-DLBCL 75
Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. 75
Molecular pathogenesis of non-Hodgkin's lymphoma: the role of Bcl-6. 74
CD30+ anaplastic large-cell lymphoma, null type, with signet-ring appearance. 74
Genetics of diffuse large b-cell lymphoma 74
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities 73
Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). 72
Genetics of follicular lymphoma transformation. 72
Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells 71
Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. 70
Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas 70
Immunotoxin therapy of hematological malignancies. 69
Signatures of murine B-cell development implicate Yy1 as a regulator of the germinal center-specific program 68
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. 67
Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. 67
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. 67
Tracking Immunoglobulin Repertoire and Transcriptomic Changes in Germinal Center B Cells by Single-Cell Analysis 65
Towards patient-based cancer therapeutics. 65
Molecular Biology of Lymphoma 65
Molecular pathogenesis of B cell malignancy: the role of BCL-6. 64
State of the Art and Future Needs in Cytogenetic/Molecular Genetics/Arrays in childhood lymphoma: summary report of workshop at the First International Symposium on childhood and adolescent non-Hodgkin lymphoma, April 9, 2003, New York City, NY. 64
The genetic landscape of diffuse large B-cell lymphoma 64
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma 62
null 62
Totale 9.824
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.083
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022743 0 0 0 61 43 11 14 291 16 35 124 148
2022/20231.607 125 313 23 144 98 170 1 72 604 5 41 11
2023/2024671 33 51 31 11 4 5 174 9 96 31 79 147
2024/20251.593 102 175 20 49 317 51 37 89 323 115 173 142
2025/20263.590 305 226 208 347 393 321 716 181 526 257 86 24
2026/2027932 66 115 271 480 0 0 0 0 0 0 0 0
Totale 11.280